You searched for Antibody candidate - Page 13 of 69 - Labiotech.eu

antibody Analytics

News and Trends 29 Jun 2022

Watch: Antibody Analytics opens new health sciences center

A new facility dedicated to the advancement of medical research and drug development opened its doors recently in Motherwell, Scotland, as part of a major expansion. Antibody Analytics, one of…

June 29, 2022 - 3 minutesmins - By Jim Cornall

ADC Therapeutics cancer antibodies2 1

News and Trends 23 Oct 2017

Swiss Biotech Rakes in $200M to Accelerate Antibody-based Cancer Treatments

ADC Therapeutics has received massive private funding to progress two of its lead candidates for cancer through clinical trials. ADC Therapeutics, based in Lausanne, Switzerland, specializes in developing antibody-drug conjugates…

October 23, 2017 - 3 minutesmins - By Alex Dale

shutterstock 548463310

News and Trends 24 Feb 2017

What are the Current Challenges in the Booming Field of ADCs?

…carboxylic acids on an antibody. Another linker-related problem in ADC development is the drug-antibody ratio (DAR): it’s difficult to pin an exact number of toxins to an antibody and even…

February 24, 2017 - 5 minutesmins - By Evelyn Warner

cancer cells

News and Trends 16 Jun 2022

Spirea raises £2.4M to develop antibody drug conjugates in cancer

…a wide range of cancers.” Better efficacy and safety Spirea’s technology allows more cytotoxic drug to be attached to the targeting antibody (a higher drug-to-antibody ratio), which means more drug…

June 16, 2022 - 3 minutesmins - By Liza Laws

ADVERTISEMENT

adc therapeutics lymphoma treatment 1

News and Trends 11 Dec 2017

New Antibody-Drug Conjugate Offers Hope to Hard-to-Treat Cancer Patients

…candidate, ADCT-402, in tough-to-treat lymphomas and leukemias were presented at the annual American Society of Hematology (ASH) Meeting. The candidate has shown potential in the treatment of Diffuse Large B-Cell…

December 11, 2017 - 3 minutesmins - By Alex Dale

podcast 40

Podcast 31 Mar 2023

Beyond Biotech podcast 40: Antibody-drug conjugates

This episode of the podcast is an in-depth look at antibody drug conjugates (ADCs). Our guests are Dr Pini Tsukerman, chief scientific of Nectin Therapeutics, and Matthew Robinson, chief technology…

March 31, 2023 - 2 minutesmins - By Jim Cornall

Best Biotech Companies Europe

Best in Biotech 2 Apr 2019

The 8 Best Biotech Companies in Europe’s History

…human antibody and the world’s best selling drug during the last few years. After selling and licensing several human antibodies to big pharma, Cambridge Antibody Technology was acquired in 2006…

April 2, 2019 - 8 minutesmins - By Clara Rodríguez Fernández

ADC antibody-drug conjugates

Podcast 7 Jul 2023

Beyond Biotech podcast 53: Antibody-drug conjugates

On the podcast this week, we have a conversation about antibody-drug conjugates with Pejvack Motlagh, who was recently announced as the chief medical officer at Mablink Bioscience. Mablink Bioscience Mablink…

July 7, 2023 - 1 minutemin - By Jim Cornall

genmab ipo nasdaq

News and Trends 17 Oct 2019

Innate Pharma Raises €62M IPO to Develop Antibody Drugs for Cancer

The French company Innate Pharma has raised a Nasdaq IPO of €62.1M ($68.8M) to fund the development of antibody immunotherapies for solid tumors and blood cancer. Innate Pharma’s lead candidate…

October 17, 2019 - 2 minutesmins - By Jonathan Smith

long covid-19

News and Trends 14 Feb 2023

Scancell looking to partner after positive COVID vaccine data

…cell response. RBD neutralizing antibody titres against the Beta variant doubled in 44% of subjects and NCAP antibody titres doubled in 42% of participants. Scancell said of particular interest was…

February 14, 2023 - 5 minutesmins - By Jim Cornall

zurich biotech octapharma ehtz switzerland

News and Trends 7 Jun 2016

Zurich is not all about Money – here are 9 Biotechs proving it!

…privately held and raised a Series A round of CHF 37.6M. It develops antibody therapeutics, including PENTRA Bodies – small, highly potent and stable antibody fragments that can penetrate tissues….

June 7, 2016 - 5 minutesmins - By Denise Neves Gameiro

Arsanis Adimab RSV monoclonal antibodies

News and Trends 28 Feb 2017

New Antibodies to Target the Respiratory Syncytial Virus

…an RSV therapy is already quite crowded, but Arsanis seems to be confident that their new antibody candidates have the potential to compete. Images via shutterstock.com / Kateryna Kon …

February 28, 2017 - 3 minutesmins - By Melanie De Almeida